摘要
目的:建立同时测定术后患者应用曲马多后的曲马多和活性代谢物O-脱甲基曲马多(M1)血药浓度的方法。方法:血浆样品50μ1以乙腈溶液150μl(含内标氟康唑)沉淀蛋白处理后,采用液.质联用(LC-MS/MS)法进样测定,色谱柱为zorbaxSB-C18,流动相为O.1%甲酸.5mmoVL乙酸铵溶液.0.1%甲酸乙腈溶液(梯度洗脱);用于定量分析的离子反应m/z分别为曲马多264.2→58.6、M1250.0→58.6、氟康唑307→220。结果:2种待分析物血药浓度均在5~1000ng/ml范围内线性关系良好,日内、日间RSD均〈10%;方法回收率分别为92.26%~100.01%、88.45%~100.60%。结论:本方法准确、快速、灵敏,可用于曲马多和M1的血药浓度测定及药动学研究。
OBJECTIVE: To establish the method for simultaneous determination of tramadol and active metabolite O-demethyl tramadol (MI) ill the plasma of postoperative patients treated with tramadol. METHODS: Tramadol and M1 in plasma were deter- mined simultaneously by LC-MS/MS after the plasma sample 50 μl was precipitated with acetonitrile 150 μl containing fluconazol. The determination was performed on Zorbax SB-Cls with mobile phase consisted of 0.1% formic acid-5 mmol/L ammonium acetate solution-0.1% formic acid acetonitrile solution (gradient elution) ; m/z was 264.2→58.6 for tramadol, 250.0→58.6 for Mt and 307→220 for fluconazol. RESULTS: The linear range of tmmadol and M1 both were 5-1 000 ng/ml; RSDs of intra-day and inter-day were lower than 10% ; method recoveries were 92.26%-100.01% and 88.45%-100.60%. CONCLUSIONS: The method is accurate, rapid and sensitive, and can be used for the determination of plasma concentration of tramadol and Mx and pharmacokinetic study.
出处
《中国药房》
CAS
CSCD
2014年第18期1662-1665,共4页
China Pharmacy
基金
浙江省科技厅资助项目(No.2010C33120)